Table 5.
Results from dose plan analysis for Patient 4
| Obj | HT | IMP | RA | |
| PTVII | ||||
| Mean [Gy] | 49.5 | 49.5 (100%) |
49.5 (100%) |
49.5 (100%) |
| D1% [%] | - | 106.9 | 106.5 | 103.2 |
| D99% [%] | - | 94.1 | 89.9 | 93.7 |
| V90% [%] | 100% | 99.9 | 98.9 | 99.8 |
| V95% [%] | 100% | 98.6 | 93.9 | 98.2 |
| V107% [%] | 0% | 0.9 | 0.7 | 0.0 |
| V110% [%] | 0% | 0 | 0 | 0 |
| SD [Gy] | - | 2.2 | 3.2 | 1.8 |
| D5–D95 [Gy] | - | 7.3 | 9.9 | 5.3 |
| CI90 | 1.0 | 2.3 | 1.3 | 1.7 |
| PTVI (left and right) | ||||
| Mean [Gy] | 45 | 44.6 (99.1%) |
44.6 (99.1%) |
45.0 (100%) |
| D1% [%] | - | 102.7 | 110.0 | 103.8 |
| D99% [%] | - | 94.0 | 85.6 | 94.4 |
| V90% [%] | 100% | 99.8 | 96.8 | 99.9 |
| V95% [%] | 100% | 98.5 | 87.5 | 99.0 |
| V107% [%] | 0% | 0 0 | 6.2 | 0 0 |
| V110% [%] | 0% | 0 0 | 1.4 | 0 0 |
| D5–D95 [%] | - | 4.0 | 13.6 | 5.6 |
| SD [%] | - | 1.6 | 4.2 | 1.8 |
| Uterus | ||||
| Mean [Gy] | < 20 Gy | 9.0 | 0.5 | 8.8 |
| D1% [Gy] | Minim | 11.4 | 4.4 | 10.7 |
| V10 Gy [%] | Minim | 12.4 | 0.0 | 4.4 |
| Rectum | ||||
| Mean [Gy] | < 40 Gy | 18.4 | 10.6 | 19.3 |
| D1% [Gy] | Minim | 52.2 | 51.0 | 49.9 |
| V40 Gy [%] | Minim | 12.4 | 11.8 | 15.4 |
| Bladder | ||||
| Mean [Gy] | < 30 Gy | 17.8 | 4.3 | 15.5 |
| D1% [Gy] | Minim | 34.3 | 35.0 | 33.0 |
| V20 Gy [%] | Minim | 21.0 | 6.5 | 19.2 |
| Right Femur | ||||
| Mean [Gy] | < 20 Gy | 14.4 | 1.5 | 18.8 |
| D1% [Gy] | Minim | 38.4 | 28.2 | 41.0 |
| Left Femur | ||||
| Mean [Gy] | < 20 Gy | 14,3 | 0.3 | 18.2 |
| D1% [Gy] | Minim | 37.2 | 10.8 | 37.7 |
| Healthy tissue | ||||
| Mean Gy] | Minim | 13.8 | 3.7 | 12.2 |
| V10 Gy [cm3] | Minim | 51.2 | 11.8 | 42.9 |
| EI [%] | Minim | 4.1 | 5.0 | 3.3 |
| DosInt [105 *Gy*cm3] | Minim | 1.1 | 0.3 | 1.0 |